United Therapeutics Corporation To Report First Quarter 2019 Financial...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , April 24, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2019 financial...
View ArticleUnited Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used...
SILVER SPRING, Md. , April 29, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc. , a subsidiary of XVIVO Perfusion AB...
View ArticleUnited Therapeutics Corporation Reports First Quarter 2019 Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , May 1, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31,...
View ArticleUnited Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous...
RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H. , May 7, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of...
View ArticleUnited Therapeutics Corporation To Present at Jefferies 2019 Healthcare...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , May 28, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond , Chief Financial Officer and...
View ArticleUnited Therapeutics Corporation to Present at Goldman Sachs 40th Annual...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 5, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond , Chief Financial Officer and...
View ArticleUnited Therapeutics Corporation To Report Second Quarter 2019 Financial...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 24, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2019 financial...
View ArticleUnited Therapeutics Corporation Reports Second Quarter 2019 Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 31, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended June 30,...
View ArticleUnited Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 6, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt , Ph.D., Chairman and Chief...
View ArticleUnited Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Sept. 11, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration ( FDA )...
View Article
